Tag: Vaxxas
Vaxxas kickstarts needle-free COVID-19 vaccine clinical trial
Australian biotechnology company Vaxxas has begun the Phase I clinical trial of the first needle-free COVID-19 vaccine candidate.
Vaxxas receives $8.2 million Commonwealth Government grant to support manufacturing scale-up in its Australian...
Media Release by Vaxxas
Vaxxas will receive an AU$8.2 million second-round grant as part of the Commonwealth Government’s Modern Manufacturing Initiative (MMI) to support the...
Construction commences of Australia’s first needle-free vaccine manufacturing facility
Vaxxas, a Queensland biotechnology business, has begun construction on a new facility in Northshore Hamilton, Brisbane to develop and manufacture its needle-free vaccination technology.
The...
Government announces $36m in funding for medical product manufacturing projects
Five medical product manufacturers will share over $36 million in grants through round 1 of the Modern Manufacturing Initiative (MMI) Translation and Integration streams.
The...
Palaszczuk Government launches $1.84 billion jobs fund
Media Release
The Palaszczuk Government has launched a new flagship program, bringing together $1.84 billion in measures designed to turbo-charge job creation in Queensland.
Premier Annastacia...
New clinical manufacturing training hub launches in Brisbane
Minister for Industry, Science and Technology Karen Andrews has officially opened the T3 Cleanrooms at the Translational Research Institute (TRI) in Brisbane that will...
Med-tech start-up to manufacture needle-free vaccine technology in Qld
Brisbane-based med-tech company Vaxxas will create up to 140 new manufacturing jobs over 10 years with support from the Palaszczuk Government.
Vaxxas, a UniQuest spin-out...
Featured Article
Navigating energy price volatility with predictive intelligence
Energy price volatility has become a structural feature of modern electricity markets rather than a temporary disruption. For energy-intensive manufacturers and large commercial operators, fluctuating wholesale prices are reshaping how energy costs are managed, making reactive approaches increasingly inadequate.
